BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31006589)

  • 21. Watch and Wait for rectal cancer in inflammatory bowel disease.
    Azevedo JGM; Fernandez L; Herrando AI; Santiago I; Pares O; Parvaiz A
    BMJ Case Rep; 2023 Jul; 16(7):. PubMed ID: 37429643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delaying surgery after neoadjuvant chemoradiotherapy in rectal cancer has no influence in surgical approach or short-term clinical outcomes.
    Figueiredo N; Panteleimonitis S; Popeskou S; Cunha JF; Qureshi T; Beets GL; Heald RJ; Parvaiz A
    Eur J Surg Oncol; 2018 Apr; 44(4):484-489. PubMed ID: 29398323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing outcomes and cost in surgery versus watch & wait surveillance of patients with rectal cancer post neoadjuvant long course chemoradiotherapy.
    Crean R; Glyn T; McCombie A; Frizelle F
    ANZ J Surg; 2024 Jun; 94(6):1151-1160. PubMed ID: 38486505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy.
    Smith JJ; Strombom P; Chow OS; Roxburgh CS; Lynn P; Eaton A; Widmar M; Ganesh K; Yaeger R; Cercek A; Weiser MR; Nash GM; Guillem JG; Temple LKF; Chalasani SB; Fuqua JL; Petkovska I; Wu AJ; Reyngold M; Vakiani E; Shia J; Segal NH; Smith JD; Crane C; Gollub MJ; Gonen M; Saltz LB; Garcia-Aguilar J; Paty PB
    JAMA Oncol; 2019 Apr; 5(4):e185896. PubMed ID: 30629084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Rational evaluation of the complete response after neoadjuvant therapy in locally advanced mid-low rectal cancer: the pros and cons of "watch and wait" strategy].
    Gu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):507-513. PubMed ID: 31238630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Long-term outcome of patients with rectal cancer who achieve complete or near complete clinical responses after neoadjuvant therapy: a multicenter registry study of data from the Chinese Watch and Wait Database].
    Zhao YM; Wang WH; Zhang W; Wang L; Li S; Wang JW; Liao LE; Yu GY; Sun Z; Qu YL; Gong Y; Lu Y; Wu T; Li YF; Wang Q; Zhao GH; Xiao Y; Ding PR; Zhang Z; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):372-382. PubMed ID: 38644243
    [No Abstract]   [Full Text] [Related]  

  • 27. Rectal cancer with complete clinical response after neoadjuvant chemoradiotherapy, surgery, or "watch and wait".
    Lai CL; Lai MJ; Wu CC; Jao SW; Hsiao CW
    Int J Colorectal Dis; 2016 Feb; 31(2):413-9. PubMed ID: 26607907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Observation of "complete clinical response" in rectal cancer after neoadjuvant chemoradiation: The Flinders experience.
    Sposato LA; Lam Y; Karapetis C; Vatandoust S; Roy A; Hakendorf P; Dwyer A; de Fontgalland D; Hollington P; Wattchow D
    Asia Pac J Clin Oncol; 2018 Dec; 14(6):439-445. PubMed ID: 29932278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term Outcome of an Organ Preservation Program After Neoadjuvant Treatment for Rectal Cancer.
    Martens MH; Maas M; Heijnen LA; Lambregts DM; Leijtens JW; Stassen LP; Breukink SO; Hoff C; Belgers EJ; Melenhorst J; Jansen R; Buijsen J; Hoofwijk TG; Beets-Tan RG; Beets GL
    J Natl Cancer Inst; 2016 Dec; 108(12):. PubMed ID: 27509881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management and Outcome of Local Regrowths in a Watch-and-wait Prospective Cohort for Complete Responses in Rectal Cancer.
    van der Sande ME; Figueiredo N; Beets GL
    Ann Surg; 2021 Dec; 274(6):e1056-e1062. PubMed ID: 32039985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Role of Probe-Based Confocal Laser Endomicroscopy (pCLE) in the Diagnosis of Sustained Clinical Complete Response Under Watch-and-Wait Strategy After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Adenocarcinoma: a Score Validation.
    Safatle-Ribeiro AV; Ribeiro U; Lata J; Baba ER; Lenz L; da Costa Martins B; Kawaguti F; Moura RN; Pennacchi C; Gusmon C; de Lima MS; de Paulo GA; Nahas CS; Marques CF; Imperiale AR; Cotti GC; Maluf-Filho F; Nahas SC
    J Gastrointest Surg; 2023 Sep; 27(9):1903-1912. PubMed ID: 37291428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wait-and-see or radical surgery for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy: a cohort study.
    Li J; Liu H; Yin J; Liu S; Hu J; Du F; Yuan J; Lv B; Fan J; Leng S; Zhang X
    Oncotarget; 2015 Dec; 6(39):42354-61. PubMed ID: 26472284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 'Watch and wait' after chemoradiotherapy for rectal cancer.
    Mullaney TG; Lightner AL; Johnston M; Keck J; Wattchow D
    ANZ J Surg; 2018 Sep; 88(9):836-841. PubMed ID: 30047201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 35. [Comparison of long-term efficacy between watch and wait strategy and total mesorectal excision in locally advanced rectal cancer patients with clinical complete response after neoadjuvant therapy].
    Wang XH; Zhou CJ; Zhang S; Wang QX; Xiao WW; Ding PR; Chen G; Pan ZZ; Zeng ZF; Gao YH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):266-273. PubMed ID: 32192306
    [No Abstract]   [Full Text] [Related]  

  • 36. [Diagnosis and treatment strategy for clinical complete responders after chemoradiotherapy for rectal cancer: is watch-and-wait policy safe?].
    Yao HW; Liu YH
    Zhonghua Wai Ke Za Zhi; 2017 Jul; 55(7):496-499. PubMed ID: 28655076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early results from implementation of a 'watch and wait' protocol for complete clinical response following chemoradiotherapy for rectal cancer.
    Balasuriya HD; Timon C; Entriken F; Neely D; Herron J; Tang C; Van Hazel G; Warner MW
    ANZ J Surg; 2022 Nov; 92(11):2961-2967. PubMed ID: 35841184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rectal cancer: Watch-and-wait and continuing the rectal-preserving strategy with local excision for incomplete response or limited regrowth.
    Al-Najami I; Jones HJ; Dickson EA; Muirhead R; Deding U; James DR; Cunningham C
    Surg Oncol; 2021 Jun; 37():101574. PubMed ID: 33853031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis.
    Chadi SA; Malcomson L; Ensor J; Riley RD; Vaccaro CA; Rossi GL; Daniels IR; Smart NJ; Osborne ME; Beets GL; Maas M; Bitterman DS; Du K; Gollins S; Sun Myint A; Smith FM; Saunders MP; Scott N; O'Dwyer ST; de Castro Araujo RO; Valadao M; Lopes A; Hsiao CW; Lai CL; Smith RK; Paulson EC; Appelt A; Jakobsen A; Wexner SD; Habr-Gama A; Sao Julião G; Perez R; Renehan AG
    Lancet Gastroenterol Hepatol; 2018 Dec; 3(12):825-836. PubMed ID: 30318451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Watch-and-Wait Compared to Operation for Patients with Complete Response to Neoadjuvant Therapy for Rectal Cancer.
    Beard BW; Rettig RL; Ryoo JJ; Parker RA; McLemore EC; Attaluri V
    J Am Coll Surg; 2020 Dec; 231(6):681-692. PubMed ID: 33121903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.